Brian Lam

Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States

Zobair M. Younossi, Maria Stepanova, Francesco Negro et al. · Medicine · 2012 · 557 citations

Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study

Anita Kohli, Rama Kapoor, Zayani Sims et al. · The Lancet Infectious Diseases · 2015 · 165 citations · Full text

Hepatology, Hepatitis C, Viral Hepatitis +11

Review: Treatment options for nonalcoholic fatty liver disease

Brian Lam, Zobair M. Younossi · Therapeutic Advances in Gastroenterology · 2010 · 110 citations · Full text

Immunology, Pathology, Fatty Liver Disease +22

A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease

Zobair M. Younossi, Janus P. Ong, Hirokazu Takahashi et al. · Clinical Gastroenterology and Hepatology · 2021 · 101 citations · Full text

Obesity, Metabolic Syndrome, Metabolic Associated Steatohepatitis +14

A disease‐specific quality of life instrument for non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis: <scp>CLDQ</scp>‐<scp>NAFLD</scp>

Zobair M. Younossi, Maria Stepanova, Linda Henry et al. · Liver International · 2017 · 100 citations